Credits Available: | 3.0 AMA PRA Category 1 Credits™; 3.0 ANCC contact hours; 3.0 ACPE contact hours |
Insulin is an integral component of diabetes management, providing greater efficacy at lowering HbA1c compared to oral agents. However, average HbA1c levels in patients receiving insulin range from 7.9 to 9.3%, highlighting the need for clinician and patient education to promote proper use of this effective therapy. This Gather-ed educational experience will focus on identifying patient and clinician barriers to insulin initiation and titration and strategies to address these barriers, evaluating efficacy and safety data for insulin, and developing patient-specific plans for insulin therapy.
The self-assessment will assess your understanding of barriers to insulin initiation, titration and adherence, strategies to address these barriers, efficacy and safety data of insulin, and developing individualized plans for insulin therapy according to patient-specific factors.
This module focuses on patient and provider barriers that delay initiation and affect adherence to insulin therapy. Therapeutic inertia and psychological insulin resistance (PIR) are addressed, as well as additional patient and provider obstacles that impact proper insulin use.
This module focuses on strategies to approach barriers that delay initiation of and affect adherence to insulin therapy. Addressing patient and clinician barriers, including therapeutic inertia and psychological insulin resistance, are essential to promote proper use of insulin.
This module focuses on considerations for individualized and timely initiation, modification, and intensification of insulin therapy. Various insulin formulations are discussed, as well as the impact of COVID-19 on patients with diabetes.
The self-assessment will assess your understanding of barriers to insulin initiation, titration and adherence, strategies to address these barriers, efficacy and safety data of insulin, and developing individualized plans for insulin therapy according to patient-specific factors.
The first web conference will focus on identifying patient and clinician barriers to insulin initiation and titration and strategies to address these barriers, evaluating efficacy and safety data for insulin, and developing patient-specific plans for insulin therapy.
The second web conference will focus on reviewing the patient case and group tasks and how the findings can apply to caring for current or future patients with diabetes with barriers to insulin therapy.
This group task will focus on clinical considerations for an adult male with type 2 diabetes.
This group task will focus on clinical considerations for an adult female with type 2 diabetes.
Thank you for your interest. Currently, the curriculum is closed for enrollment but we encourage you to keep an eye out for future opportunities or alternative programs that might align with your educational goals.